Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Glycine
Selected research topic
Blood pressure and vascular health
Confirmed comparison evidence for this topic is limited. The findings below retain their study conditions.
Some findings concern patients or people with a deficiency.
- Publications for this topic
- 3
- Human comparison publications
- 0
- Publications needing review
- 0
Findings in the studies
BP differences
Other human research, including observational studies and reviews
- An association was observed. This does not establish that the ingredient caused the change.General population · Cross-sectional
Measurement and study conditions
- Study type
- Observational study
- Study population
- Human participants · General population
- Ingredients tested
- Unknown intervention
- How results were compared
- Comparison unclear · Study comparison: Higher dietary glycine intake associated with greater systolic BP differences; dietary exposure, not
- Additional measurement information
- Secondary outcome
- Measurement time
- Cross-sectional
systolic blood pressure
Other human research, including observational studies and reviews
- A change was reported, but the comparison could not be confirmed.Patient group · Single ingredient
Measurement and study conditions
- Study type
- Randomized controlled trial: subjects were randomly assigned to groups for comparison.
- Study population
- Human participants · Patient group
- Ingredients tested
- Single ingredient
- Measurement time
- Not confirmed.
hypertension
Research with unclear study subject or type
- A change was reported, but the comparison could not be confirmed.Single ingredient
Measurement and study conditions
- Study type
- Review
- Study population
- Recorded population category: Patient group. Whether the research involved humans needs confirmation.
- Ingredients tested
- Single ingredient
- How results were compared
- Study comparison: Review-level summary claim for glycine supplementation; no comparator specified
- Measurement time
- Not confirmed.
Representative outcome and study details
Human studies reported an association with BP differences.
Scope not specified · Human studies · comparator not confirmed
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: C
The 32.2 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 93
Papers linked to this topic 3 · distinct papers 3 · comparison findings need further review · papers needing additional review 0
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- BP differences: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- hypertension: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- systolic blood pressure: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
What the research found
BP differences
An association was observed. This does not establish that the ingredient caused the change.
Observational study · Unknown intervention · General population
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
hypertension
A change was reported, but the comparison could not be confirmed.
Review · Single ingredient · Patient group
Analysis coverage and paper counts
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
systolic blood pressure
A change was reported, but the comparison could not be confirmed.
Controlled study in people · Single ingredient · Patient group
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No combination cautions are available to show in the current data. This does not guarantee safety.
Review 1 combination findings and 0 findings that outperformed an ingredient alone.
Reported improvements with combinations
Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.
Combinations with reported improvement
The combination showed improvement, but each ingredient's contribution is unclear.
NACIn a randomized clinical trial of older adults, GlyNAC (a combination of glycine and NAC) supplementation for 16 weeks improved glutathione deficiency, oxidative stress, and mitochondrial dysfunction compared to placebo.